| 영문 | Dilatation and Curettage(D & C) | 한글 | 자궁긁어냄술, 자궁목확장 |
|---|---|---|---|
| 설명 | 자궁이란 태아가 수태되어서 분만전까지 발육하고 성장하는 공간이다. 자궁속에 병변이 있어 임신이 계속될 수 없거나 아니면 다른 이유로 임신되어 있는 태아를 제거하고자 할 경우에 사용되는 방법이다. 여기서 긁어내기 위하여는 우선 자궁의 입구에 해당하는 자궁목을 확장시켜야 한다. 여기에는 급속히 확장을 시도하는 법과 서서히 확장을 시도하는 2가지 방법이 있다. 자궁목을 급속히 확장할 때는 헤가르 목관확장기(Hegar's dilatator)를 사용한다. 이것은 작은 금속막대로 작은 크기부터 큰 크기까지 다양한 크기가 있어서 우선 작은 막대로 시작하여 점점 큰 크기의 막대를 자궁목에 넣어서 자궁목을 확장시킨다. 서서히 확장시킬 때는 Laminaria tent를 목관에 삽입하는 방법을 사용한다. Laminaria tent란 해초로 만든 작은 막대로 수분을 흡수하면 점점 늘어나는 성질이 있다. 이것을 자궁의 목에 넣으면 이것이 수분을 흡수하여 늘어나므로 천천히 자궁의 목이 늘어난다. 자궁목이 충분히 늘어나면 그 속으로 끝이 숟가락처럼 생긴 기구를 넣어서 자궁속의 병변이나 임신된 태아를 긁어내는데 여기에 사용되는 숟가락처럼 생긴 기구를 큐렛이라고 한다. 초기 임신중절 즉 유산과 같은 임신과 관련된 경우뿐만 아니라, 비임신 자궁의 자궁내막조직의 채취 및 제거를 위해서도 행해지는 수기이다. 이는 원칙적으로 마취하에 실시되는 것으로 자궁목관을 확장하고 기구로 자궁 내용물을 제거하고 큐렛으로 자궁내벽을 깨끗이 한다. 자궁천공이나 자궁목의 파열 등의 위험이 따르며, 수술후 감염 또는 출혈 등에 대한 주의가 필요하다. |
||
| 영문 | stool culture | 한글 | 대변 배양 |
|---|---|---|---|
| 설명 | 대변을 대변통에 적당량 담아 보내고, 직장도말(rectal swab: 직접 항문에서 대변을 묻혀서 받아내는 것)검체는 두개의 면봉을 운반배지에 넣어 보낸다. 먼저 그람염색하여 백혈구가 보이는 지를 관찰하고 백혈구가 많이 보이면 대부분 세균성 이질일 가능성이 높다. 배양방법은 균에 따라 다르며 살모넬라(Salmonella)는 S-S 우무에 배양하며 옐시니아(Yersinia)는 CIN 우무에 배양하며, 비브리오(Vibrio)는 TCBS 우무에 배양하며, 클로스트리듐(Clostridium)은 TCCF 우무에 배양하며, 최근 발견된 장용혈성 대장균(EHEC)은 sorbital MAC 우무에서 배양한다. |
||
| 영문 | culture | 한글 | 배양 |
|---|---|---|---|
| 설명 | 미생물을 인공적 환경을 제공하여 자라게 하는 것이다. 배양특징은 산소가 있으면 더욱 잘 자라며 배양시 줄모양을 형성함. 10%의 이산화탄소에 의해 성장이 촉진된다. |
||
| TC | target cell; taurocholate; temperature compensation; teratocarcinoma; tertiary cleavage; tetracyclin... |
|---|---|
| MLC | minimum lethal concentration; mixed leukocyte culture; mixed ligand chelate; mixed lymphocyte concen... |
| TCID | tissue culture infective dose; tissue culture inoculated dose |
| TCID50 | median tissue culture infective dose; 50% tissue culture infective dose |
| C&S | calvarium and scalp; conjunctiva and sclera; culture and sensitivity |
| NIST | National Institute of Standards and Technology |
|---|---|
| ART | Assisted Reproductive Technology |
| FDT | Frequency Doubling Technology |
| HTA | Health Technology Assessment |
| IVET | In vivo expression technology |
| antibody technology | <molecular biology> Techniques for the synthesis of polyclonal and monoclonal antibodies for use in research, diagnostics and therapeutics. (09 Feb 1998) |
|---|---|
| assisted reproductive technology | Originally, a range of techniques for manipulating eggs and sperm in order to overcome infertility. Encompasses drug treatments to stimulate ovulation; surgical methods for removing eggs (e.g., laparoscopy and ultrasound-guided transvaginal aspiration) and for reimplanting embryos (e.g., zygot intrafallopian transfer (or ZIFT); in vitro and in vivo fertilization (e.g., artificial insemination and gamete intrafallopian transfer (or GIFT); ex utero and in utero foetal surgery; as well as laboratory regimes for freezing and screening sperm and embryos, and micromanipulating and cloning embryos. The field's first major success came in 1978 with the birth of "test-tube baby" Louise Brown, engineered by Steptoe, Edwards, et al., of England. As the technologies spread, they increasingly are being employed for purposes beyond infertility, i.e., to reduce the risk of, or avoid passing on, hereditary disease and to select for infant sex. Further uses that would aim at improving the "quality" of offspring have been widely discussed and raise profound legal and ethical questions. See: eugenics. (05 Mar 2000) |
| recombinant DNA technology | A series of procedures used to join together (recombine) DNA segments. A recombinant DNA molecule is constructed (recombined) from segments from 2 or more different DNA molecules. Under certain conditions, a recombinant DNA molecule can enter a cell and replicate there, autonomously (on its own) or after it has become integrated into a chromosome. (12 Dec 1998) |
| national centre for health care technology | A centre in the public health service which coordinates and administers a program of research, demonstrations, and evaluations of medical technologies and assessments of health care technology. (12 Dec 1998) |
| DNA technology, recombinant | A series of procedures used to join together (recombine) DNA segments. A recombinant DNA molecule is constructed (recombined) from segments from 2 or more different DNA molecules. Under certain conditions, a recombinant DNA molecule can enter a cell and replicate there, autonomously (on its own) or after it has become integrated into a chromosome. (12 Dec 1998) |
| technology | <study> Industrial science; the science of systematic knowledge of the industrial arts, especially of the more important manufactures, as spinning, weaving, metallurgy, etc. Technology is not an independent science, having a set of doctrines of its own, but consists of applications of the principles established in the various physical sciences (chemistry, mechanics, mineralogy, etc) to manufacturing processes. Origin: Gr. An art; cf. Gr. Systematic treatment: cf. F. Technologie. Source: Websters Dictionary (01 Mar 1998) |
| technology assessment, biomedical | Evaluation of biomedical technology in relation to cost, efficacy, utilization, etc., and its future impact on social, ethical, and legal systems. (12 Dec 1998) |
| technology, dental | The field of dentistry involved in procedures for designing and constructing dental appliances. It includes also the application of any technology to the field of dentistry. (12 Dec 1998) |
| technology, high-cost | Advanced technology that is costly, requires highly skilled personnel, and is unique in its particular application. Includes innovative, specialised medical/surgical procedures as well as advanced diagnostic and therapeutic equipment. (12 Dec 1998) |
| technology, medical | The application of scientific knowledge or technology to the field of medicine. It includes a variety of medical diagnostic and clinical laboratory procedures. Medical technology is also considered a specialty. (12 Dec 1998) |
| technology, medical laboratory | The application of scientific knowledge or technology in medical laboratories as facilities equipped to carry out investigative procedures in the diagnosis and therapy of disease. It includes methods, techniques, and instrumentation used in medical laboratories. (12 Dec 1998) |
| technology, pharmaceutical | The application of scientific knowledge or technology to pharmacy, pharmacology, and the pharmaceutical industry. It includes methods, techniques, and instrumentation in the manufacture, preparation, compounding, dispensing, packaging, and storing of drugs and other preparations used in diagnostic and determinative procedures and in the treatment of patients. (12 Dec 1998) |
| technology, radiologic | The application of scientific knowledge or technology to the field of radiology. The applications centre mostly around X-ray or radioisotopes for diagnostic and therapeutic purposes but the technological applications of any radiation or radiologic procedure is within the scope of radiologic technology. (12 Dec 1998) |
| technology, recombinant DNA | A series of procedures used to join together (recombine) DNA segments. A recombinant DNA molecule is constructed (recombined) from segments from 2 or more different DNA molecules. Under certain conditions, a recombinant DNA molecule can enter a cell and replicate there, autonomously (on its own) or after it has become integrated into a chromosome. (12 Dec 1998) |
| technology transfer | The process of converting scientific findings from research laboratoriesinto useful products by the commercial sector. (09 Oct 1997) |
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|